$PBH

PREMIUM BRANDS HOLDINGS CORPORATION REPORTS RECORD SECOND QUARTER SALES, ADJUSTED EBITDA AND ADJUSTED EARNINGS AND DECLARES THIRD QUARTER DIVIDEND

Premium Brands Holdings (TSX: PBH) reported record Q2 2026 results. Revenue rose to $2.4B, up 26.3% year over year, with 7.5% organic sales growth. Adjusted EBITDA from continuing operations increased to $225.0M and adjusted EPS to $1.53. The company declared a $0.85 dividend for Q3 and revised 2026 guidance due to delayed promotions/new product launches.

Original reporting
Published Aug 6, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
PREMIUM BRANDS HOLDINGS CORPORATION REPORTS RECORD SECOND QUARTER SALES, ADJUSTED EBITDA AND ADJUSTED EARNINGS AND DECLARES THIRD QUARTER DIVIDEND — source image
Decision brief

The 30-second read

$PBHBullishMed
01

Why it matters

Key decision points for traders are the record Q2 financials, the revised 2026 guidance tied to launch timing, the declared third-quarter dividend, and the completed sale of its 74% interest in Shaw Bakers.

02

Market read

This is a company-specific earnings and guidance update with additional capital return and portfolio actions, likely to drive PBH’s near-term trading around the results and investor Q&A.

03

What to watch

The excerpt mentions shutdown of an older beef processing facility and discontinued operations from Shaw Bakers and Duso’s; traders may need to separate continuing vs discontinued performance and assess margin/capex implications not fully detailed here.

Relevance 8/10Novelty 7/10Timing: today’s Q2 results and Q&A at 10:30 a.m. Vancouver time

Background

Premium Brands Holdings Corporation (PBH) released Q2 2026 results, discussed progress in Specialty Foods’ U.S. growth initiatives, and provided updated 2026 guidance ranges.

Company-level read

Ticker impact

$PBHBullishMedium confidence
Context

Premium Brands reports record Q2 revenue of $2.4B, record adjusted EBITDA of $225M, and revised 2026 guidance due to delayed promotions and new product launches.

Expected impact

Bias to the upside on the earnings/guidance and cash-flow/dividend signal, with some offset from the guidance reset tied to delayed launches.

Evidence & confidence

The article discloses specific Q2 outperformance metrics, a dividend of $0.85/share, a completed sale of its 74% Shaw Bakers interest, and a guidance revision driven by timing delays. Those are actionable fundamentals, but the magnitude of the guidance change is not quantified in the excerpt.

Market effects

Signals strength in branded specialty food demand and execution, while highlighting execution risk from promotion and new product launch timing.

Canadian-headquartered issuer with meaningful U.S. growth initiatives; results may influence sentiment toward Canada-U.S. specialty food supply chains.

Limited direct global spillover, but reinforces broader food-industry themes of protein, convenience, and premiumization.

Counterpoint

The guidance revision driven by delayed promotions and new product launches could indicate weaker near-term momentum than the headline record quarter suggests.

Key entities

  • Premium Brands Holdings Corporation

    Reports record Q2 2026 revenue, adjusted EBITDA, adjusted EPS, free cash flow, declares a dividend, completes sale of Shaw Bakers interest, and revises 2026 guidance.

  • Shaw Bakers

    Premium Brands sold its 74% interest, with operations treated as discontinued operations under IFRS.

Related articles

$PBHMed

Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover?

Prestige Consumer Healthcare (NYSE:PBH) reported Q1 fiscal 2027 sales of $265.7M (+6.5% YoY) and adjusted diluted EPS of $0.98. The company closed Breathe Right (June 12) and LaCorium Health (July 1), adding about $240M annualized revenue and raising FY sales guidance to $1.29B-$1.315B and adjusted EPS to $4.55-$4.65. Clear Eyes faces supply constraints; acquisitions were funded with new debt.

$PBHMed

Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript

Prestige Consumer Healthcare (PBH) reported Q1 fiscal 2027 sales of about $266 million, up 6.5%, with growth led by GI brands such as Dramamine and Fleet and skin care brands including Compound W. Adjusted EPS rose to $0.98 and adjusted free cash flow reached $83.7 million. PBH also completed acquisitions of the Breathe Right portfolio (closed June 12) and LaCorium (July 1).

$PBHHigh

Prestige Consumer Healthcare Inc. (PBH): Results of Operations and Financial Condition

Prestige Consumer Healthcare Inc. (PBH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991fy27-q1earningsr.htm EX-99.1 Document Exhibit 99.1 Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results • Q1 Revenue of $265.7 million up 6.5% versus prior year • Q1 Organic sales growth of 3.2%, exceeding expectations • Q1 Diluted EPS o

$PBHMed

Prestige Consumer Healthcare Inc. (PBH): Completion of Acquisition or Disposition of Assets

Prestige Consumer Healthcare Inc. (PBH) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001295947 0001295947 2026-06-12 2026-06-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of repor

$RIOTMedAI 8/10

Riot Platforms sold 4,300 bitcoin in Q2 2026 earnings

Riot Platforms said it sold 4,300 BTC in Q2 2026 to fund operations and AI data center expansion. It mined 1,587 BTC, up 11% YoY, but mining revenue fell 19% to $113.7M due to lower bitcoin prices. Quarterly revenue rose 14% to $174.2M, net loss was $237.2M, and it ended with $1.2B liquid assets. Riot also reported major Rockdale AI capacity contracts.